New diabetes drugs can reduce the risk of heart and kidney diseases
Lifestyle | Jun 13, 2017, 02:23 PM ISTThe findings published in the New England Journal of Medicine, revealed that the drug called canagliflozin, reduce the risk of cardiovascular disorders by up to 14% and heart failure hospitalization by 33%.